Showing results (281-290 of 387) with videos related to
Sort By:
Pageof 39
Brain and Behavior|March 1, 2021
Nonmotor symptom burden grading as predictor of cognitive impairment in Parkinson's diseasePanteleimon Oikonomou, Daniel J van Wamelen, Daniel Weintraub, et al.Journal of Parkinson'S Disease|August 4, 2020
Hallucinations and Development of Dementia in Parkinson's DiseaseWojciech Gryc, Kathryn A Roberts, Cyrus P Zabetian, et al.Plos One|May 26, 2017
Regional brain amyloid-β accumulation associates with domain-specific cognitive performance in Parkinson disease without dementiaRizwan S Akhtar, Sharon X Xie, Yin J Chen, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 18, 2014
Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotypeChristine R Swanson, Katherine Li, Travis L Unger, et al.Plos Medicine|October 12, 2019
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysisMarijan Posavi, Maria Diaz-Ortiz, Benjamine Liu, et al.JAMA Neurology|January 6, 2025
An Acetylcholine M1 Receptor-Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment: A Phase 2 Randomized Clinical TrialNiraj M Shanbhag, Jaya L Padmanabhan, Zheng Zhang, et al.Movement Disorders : Official Journal of the Movement Disorder Society|April 23, 2014
Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study groupIva Stankovic, Florian Krismer, Aleksandar Jesic, et al.Journal of Parkinson'S Disease|April 8, 2017
Neuropsychological Subgroups in Non-Demented Parkinson's Disease: A Latent Class AnalysisLaura Brennan, Kathryn M Devlin, Sharon X Xie, et al.Movement Disorders : Official Journal of the Movement Disorder Society|March 5, 2015
Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseDaniel Weintraub, Tanya Simuni, Chelsea Caspell-Garcia, et al.Journal of Geriatric Psychiatry and Neurology|January 10, 2012
Sertraline for the treatment of depression in Alzheimer disease: genetic influencesMatthew E Peters, Vijay Vaidya, Lea T Drye, et al.Pageof 39